Transgenic approaches to reintegration

Cardiovascular Research

Volumn 71, Issue 1, 2006, Pages 8-9

  Law, William R ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE DERIVATIVE; ADENOSINE DEAMINASE; ERYTHRO 2 (2 HYDROXY 3 NONYL)ADENINE; PENTOSTATIN; UNCLASSIFIED DRUG;

ALLOSTERISM; EDITORIAL; FIBROBLAST; GENETIC CODE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MOLECULAR RECOGNITION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RECEPTOR, ADENOSINE A1;

EID: 33745048500     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.05.013     Document Type: Editorial

References (13)

1. Willems L., Reichelt M.E., Molina J.G., Sun C.X., Chunn J.L., Ashton K.J., et al. Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovasc Res 71 (2006) 79-87
2. Dubey R.K., Gillespie D.G., Mi Z., and Jackson E.K. Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth. Hypertension 37 (2001) 1095-1100
3. Conlon B.A., Ross J.D., and Law W.R. Advances in understanding adenosine as a plurisystem modulator in sepsis and the systemic inflammatory response syndrome [SIRS]. Front Biosci 10 (2005) 2548-2565
4. Sandhu G.S., Burrier A.C., and Janero D.R. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am J Physiol 265 (1993) H1249-H1256
5. Manthei S.A., Reiling C.M., Van D., and Wylen G. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition. Cardiovasc Res 37 (1998) 171-178
6. Abd-Elfattah A.S., Jessen M.E., Lekven J., and Wechsler A.S. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury. Mol Cell Biochem 180 (1998) 179-191
7. Peart J., Matherne G.P., Cerniway R.J., and Headrick J.P. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart. Cardiovasc Res 52 (2001) 120-129
8. Szentmiklosi A.J., Nemeth M., Cseppento A., Szegi J., Papp J.G., and Szekeres L. Effects of hypoxia on the guinea-pig myocardium following inhibition of adenosine deaminase by coformycin. Arch Int Pharmacodyn Ther 269 (1984) 287-294
9. McClanahan T.B., Ignasiak D.P., Martin B.J., Mertz T.E., and Gallagher K.P. Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs. Basic Res Cardiol 90 (1995) 176-183
10. Li Y., and Kloner R.A. Adenosine deaminase inhibition is not cardioprotective in the rat. Am Heart J 126 (1993) 1293-1298
11. Grem J.L., King S.A., Chun H.G., and Grever M.R. Cardiac complications observed in elderly patients following 2′-deoxycoformycin therapy. Am J Hematol 38 (1991) 245-247
12. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59 (2000) 13-23
13. Meldrum D.R., Dinarello C.A., Cleveland Jr. J.C., Cain B.S., Shames B.D., Meng X., et al. Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism. Surgery 124 (1998) 291-296